Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00487578 · ClinicalTrials.gov registry record · Phase 4
Naratriptan for the Treatment of Post Traumatic Headache Associated With Cognitive Dysfunction
A Phase 4 study, sponsored by Cady, Roger, M.D..
- Terminated
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
NCT00487578 is a Phase 4 study that was terminated before completion, run by Cady, Roger, M.D.. The registered enrollment target is 12 participants.
The verdict
NCT00487578, a Phase 4 study, was terminated before completion, sponsored by Cady, Roger, M.D..
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether naratriptan, a medication approved for treatment of migraine, is effective in the treatment of post traumatic headache associated with cognitive dysfunction.
Interventions
- DRUG naratriptan HCl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2006-10 |
| Est. Completion | 2009-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00487578
The ClinicalTrials.gov registry entry for NCT00487578 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cady, Roger, M.D., which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which naratriptan HCl is the first listed.
NCT00487578 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00487578 about?
NCT00487578 is a clinical study titled "Naratriptan for the Treatment of Post Traumatic Headache Associated With Cognitive Dysfunction". The purpose of this study is to determine whether naratriptan, a medication approved for treatment of migraine, is effective in the treatment of post traumatic headache associated with cognitive dysfunction.
What is the current status of trial NCT00487578?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2006-10. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00487578?
The interventions under investigation include: naratriptan HCl (DRUG).
Who is sponsoring clinical trial NCT00487578?
This trial is sponsored by Cady, Roger, M.D., which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.